WallStreetZenWallStreetZen

NASDAQ: RNAC
Cartesian Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cartesian Therapeutics earnings were -$42.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest RNAC earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$17.7M, up 72.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RNAC reported annual earnings of -$77.4M, with -64.8% growth.

RNAC earnings history

Current Revenue
$34.2M
Current Earnings
-$42.5M
Current Profit Margin
-124.4%

RNAC Return on Equity

Current Company
N/A
Current Industry
-60.2%
Current Market
29.1%

RNAC undefined

Current Company
-10.3%
Current Industry
0.3%
RNAC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RNAC announces earnings.

RNAC undefined

Current Company
-9.65%
Current Industry
8.1%
RNAC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RNAC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RNAC-$33.79M-$42.52MN/A-$1.10
ABEO-$56.62M-$63.73MN/A-$1.55
IMMPN/A-$27.59MN/A-$0.21
AURA-$84.11M-$86.92MN/A-$1.75
TSVT$2.54M-$4.09MN/A-$0.08
View Top Biotech Stocks

Cartesian Therapeutics Earnings Reports & History FAQ

What were Cartesian Therapeutics's earnings last quarter?

On RNAC's earnings call on Invalid Date, Cartesian Therapeutics (NASDAQ: RNAC) reported Q1 2025 earnings per share (EPS) of -$0.68, up 93.52% year over year. Total RNAC earnings for the quarter were -$17.71 million. In the same quarter last year, Cartesian Therapeutics's earnings per share (EPS) was -$10.50.

If you're new to stock investing, here's how to buy Cartesian Therapeutics stock.

Is Cartesian Therapeutics profitable or losing money?

As of the last Cartesian Therapeutics earnings report, Cartesian Therapeutics is currently losing money. Cartesian Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$38.31 million, a 84.97% decrease year over year.

What was RNAC's earnings growth in the past year?

As of Cartesian Therapeutics's earnings date in Invalid Date, Cartesian Therapeutics's earnings has grown year over year. RNAC earnings in the past year totalled -$42.52 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.